Related Experiment Video
Updated: Jul 4, 2026

07:52
Cryo-Electron Microscopy Screening Automation Across Multiple Grids Using Smart Leginon
Published on: December 1, 2023
A roadmap for caGrid, an enterprise Grid architecture for biomedical research
Joel Saltz1, Shannon Hastings, Stephen Langella
1Biomedical Informatics Department, The Ohio State University, Columbus, OH, USA.
Studies in Health Technology and Informatics
|June 19, 2008
Summary
caGrid, a middleware for cancer research informatics, is evolving. Future directions focus on enhancing its generic framework for broader biomedical and healthcare applications, incorporating community feedback for improvements.
Area of Science:
- Biomedical Informatics
- Grid Computing
- Service-Oriented Architecture
Background:
- caGrid is a middleware system integrating Grid, Service-Oriented, and Model-Driven Architectures.
- It supports interoperable data and analytical resources within a Grid environment.
- caGrid is a core component of the National Cancer Institute's cancer Biomedical Informatics Grid (caBIG) program.
Purpose of the Study:
- To outline future architectural and tooling directions for caGrid.
- To identify areas for improvement based on community feedback and use cases.
- To explore the generic framework's applicability beyond cancer research.
Main Methods:
- The study is based on discussions from a roadmap workshop.
- Participants included experts from biomedical research, Grid computing, and high-performance computing.
- Feedback and use cases from the caGrid community were considered.
Main Results:
- The paper discusses potential future architecture and tooling for caGrid.
- Identified areas for improvement and new functionalities were considered.
- The generic nature of caGrid for broader biomedical and healthcare applications was highlighted.
Conclusions:
- caGrid's development is ongoing, driven by community input.
- The system's generic framework supports diverse biomedical research and healthcare domains.
- Future enhancements aim to improve interoperability and accelerate translational research.

